Evodiamine, a constituent isolated from the dried, unripe fruit of Evodia rutaecarpa BENTHAM (go-shu-yu in Japanese) has been reported to present bronchial contractive, 1) catecholamine secretory, 2) vasodilatory, 3, 4) anti-nociceptive 5) and antitumor effect.
Evodiamine, a constituent isolated from the dried, unripe fruit of Evodia rutaecarpa BENTHAM (go-shu-yu in Japanese) has been reported to present bronchial contractive, 1) catecholamine secretory, 2) vasodilatory, 3, 4) anti-nociceptive 5) and antitumor effect.
6) It was also reported that evodiamine had an inhibitory effect on tumor cell migration in vitro. 7) Our previous study showed that up-regulation of Bax/Bcl-2 amplified the activation of caspase cascade, resulting in apoptosis in A375-S2 cells. Additionally, simultaneous activation of p38 mitogen-activated protein kinase (MAPK) and inhibition of extracellular signal-regulated protein kinase (ERK) activity contributed to evodiamine-induced necrosis at later stage. 8) Interleukin 1 (IL-1) is one of the multifunctional cytokines produced predominantly by activated monocytes and macrophages. 9) Among the IL-1 family, IL-1a and IL-1b are referred to be "agonist" molecules that exert not only pleiotropic effects in host reactions such as immune defence, inflammation and homeostasis, 10, 11) but also regulates a variety of cell functions of many cell types in both positive and negative manners. [12] [13] [14] [15] However, the third member IL-1 receptor antagonist (IL-1Ra) binds to the same receptors as IL1a or b, but does not induce any intracellular signal, therefore, acts as a natural inhibitor of IL-1.
11) Previous studies reported that IL-1 induced growth inhibition in human melanoma cells through down-regulation of ornithine decarboxylase (ODC), 16, 17) up-regulation of IL-6 18) and cell cycle arrest. 19) Research carried out by Itoh and his coworkers also indicated that this antiproliferative effect was mediated by p38 MAPK. 20) Our study has further confirmed that induction of Fas-ligand (Fas-L), activation of caspases, regulation of Bcl-2 family proteins and induction of endogenous IL-1b also contributed to IL-1b-induced A375-S2 cell death (data not shown). Therefore, there seem to be some similarities between evdiamine's and IL-1's anti-tumor machinery.
Engagement of the extracellular domain of Fas by the Fas-L results in intracellular recruitment of caspase-8 to Fas via the adaptor protein, Fas-associated death domain (FADD) protein, because FADD interacts with Fas through its death domain and with caspase-8 through a death effector domain. 21 ) Activation of caspase cascade was responsible for the consequent process that couples DNA damage and p53 activation to pro-or anti-apoptotic machinery involves in the Bcl-2 family proteins. 8, 22) Bcl-2 family was known to play essential roles in DNA damage-induced apoptosis. 23, 24) In addition, p53 induction increases pro-apoptotic Bax synthesis 25) and activates Ras/Raf/MAPK cascade. 26) In the present study, we demonstrated that evodiamine induced A375-S2 melanoma cell death partially through IL-1 mediated pathway. Human melanoma is the most aggressive form of skin cancer and is becoming resistant to all current modalities of cancer therapy. The major aim of our study is to find out new target of natural product and develop specific drug for human melanoma.
MATERIALS AND METHODS
Reagents Evodiamine was obtained from Beijing Institute of Biological Products (Beijing, China); and its purity was determined to be about 98% by HPLC measurement. Evodiamine was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution and diluted by RPMI-1640 (Gibco, Grand Island, NY, U.S.A.) before the experiments. DMSO concentration in all cell culture was kept below 0.001%, which had no detectable effect on cell growth or death.
Human recombinant IL-1b and IL-1Ra proteins expressed by transfected Escherichia coli in our laboratory were purified by chromatography on DEAE-Sepharose Fast Flow (Amersham Pharmacia Biotech, Uppsala, Sweden) and concentrated by dialysis membrane. The purified recombinant proteins with theoretical molecular mass were analyzed by 15% polyacrylamide gel electrophoresis with sodium dodecyl sulfate (SDS-PAGE).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium (MTT), polymyxin B, and RNase were obtained from Sigma Chemical (St. Louis, MO, U.S.A.). Proteinase K was purchased from Merck (Darmstadt, Germany). TACS TM 2 TdT-DAB In Situ Apoptosis Detection Kit was purchased from Trevigen (Gaithersburg, MD, U.S.A.). Rabbit polyclonal antibodies against phospho-p53, p38, phospho-p38, ERK, Bax, Fas-L, caspase-8 and -3, mouse polyclonal antibodies against p53, phospho-ERK, Bcl-2, and horseradish peroxidase-conjugated secondary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Rabbit polyclonal anti serum against IL-1a and IL-1b were prepared in our laboratory and diluted into 1 : 1000.
Cell Culture A375-S2, human melanoma cells, were obtained from American Type Culture Collection (ATCC, #CRL, 1872, MD, U.S.A.) and were cultured in RPMI-1640 medium supplemented with 10% heat inactivated (56°C, 30 min) fetal calf serum (Beijing Yuanheng Shengma Research Institution of Biotecnology, Beijing, China), 2 mM Lglutamine (Gibco, Grand Island, NY, U.S.A.), 100 kU/l penicillin and 100 mg/l streptomycin (Gibco) at 37°C in 5% CO 2 . The cells in the exponential phase of growth were used in the experiments.
Cytotoxicity Assay A375-S2 cells were dispensed in 96-well flat bottom microtiter plates (NUNC, Roskilde, Denmark) at a density of 5ϫ10 4 cells per well. After 12 h incubation, they were treated with or without IL-1Ra, 2 h prior to the administration of 15 mM evodiamine. Then the cells were cultured for further 24, 48 h, and 15 ml MTT solution (5.0 mg/ml) was added to each well followed by 4 h coincubation, and resulting crystals were dissolved in DMSO. Absorbance was measured with a plate reader (Bio-Rad, Hercules, CA, U.S.A.). The percentage of cell growth inhibition was calculated as follows:
Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick End-Labeling (TUNEL) Assay The TUNEL Assay was used for detection of DNA strand breaks. The detection was carried out according to the instructions of TACS TM 2 TdT-DAB In Situ Apoptosis Detection Kit. Briefly, the cells were rinsed once with PBS and fixed in 3.7% buffered formaldehyde at room temperature for 10 min. The fixed sections were pretreated with 10% H 2 O 2 , and end-labeling was performed with TdT labeling reaction mix for 37°C for 1 h. Nuclei exhibiting DNA fragmentation were visualized by incubation in 3Ј,3-diamino benzidine (DAB) for 7 min. At last the section were counterstained with methyl green and observed by light microscopy. The nuclei of apoptotic cell were stained dark brown, TUNEL-positive A375-S2 cells were determined by randomly counting 100 cells.
DNA Extraction and Detection of DNA Fragmentation Both adherent and non-adherent cells (1ϫ10 6 cells) were harvested and centrifuged at 1000ϫg for 10 min, and washed three times in Ca 2ϩ -and Mg 2ϩ -free phosphate buffered saline (PBS). Cell pellets were lysed in 100 ml cell lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM EDTA pH 8.0, 0.5% Triton X-100) at 4°C for 30 min, and centrifuged at 7000ϫg for 20 min. Then the supernatants were incubated with 40 mg/ml proteinase K and 40 mg/ml RNase A, at 37°C for 2 h. The lysate was extracted with 0.5 M NaCl and 50% 2-propanol and incubated at Ϫ20°C overnight, and centrifuged at 7000ϫg for 20 min. The pellets were suspended in TE buffer (10 mM Tris-HCl pH 7.4 and 1 mM EDTA pH 8.0). DNA was separated by 2% agarose gel electroporesis at 100 V for 40 min and stained with 0.1 mg/ml ethidium bromide.
Western Blot Analysis A375-S2 cells were treated with 15 mM evodiamine for 0, 6, 12, 24, and 48 h or preincubated with or without IL-1Ra for 2 h, followed by treatment with evodiamine for another 24 h. Both adherent and floating cells were collected. Then Western blot analysis was carried out with some modification. 27) Briefly, the cell pellets were resuspended in lysis buffer, including 50 mM Hepes, pH 7.4, 1% Triton-X 100, 2 mM sodium orthovanadate, 100 mM sodium fluoride, 1 mM edetic acid, 1 mM PMSF (Sigma), 10 mg/ml aprotinin (Sigma), 10 mg/ml leupeptin (Sigma), and lysed on ice for 60 min. After centrifugation of the cell suspension at 13000ϫg for 15 min, the protein content of supernatant was determined by Bio-Rad protein assay reagent (Bio-Rad, Hercules, CA, U.S.A.). The protein lysates were separated by electrophoresis in 12% SDS polyacrylamide gel electrophoresis and blotted onto nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ, U.S.A.). After blocked with Tween 20-Tris-buffer saline [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 0.02% Tween 20] containing 5% nonfat milk at room temperature, the membrane was incubated with the indicated antibodies in blotting buffer, followed by addition of secondary antibody conjugated with horseradish peroxidase (HRP) and 3,3-diaminobenzidine tetrahydrochloride (DAB) as HRP substrate. The quantitation of Western blotting were carried out by Laser based PDSI densitometer (GE Health Care).
Statistical Analysis All data represent at least three independent experiments and are expressed as meanϮS.D. Significant changes were assessed using Student's t test for unpaired data, and p-valuesϽ0.05 were considered statistically significant.
RESULTS

IL-1Ra Partially Attenuated Cytotoxic Effect of Evodiamine on A375-S2 Cells
To investigate whether or not IL1Ra affected evodiamine-induced A375-S2 cell death, the cells were pretreated with 5 mM IL-1Ra 2 h prior to the administration of evodiamine 15 mM (IC 50 at 24 h) for 24 and 48 h. 5 mM IL-1Ra completely reversed 1 nM IL-1b-induced cell death in A375-S2 cells (Fig. 1A) . As shown in Fig. 1B , 5 mM IL-1Ra decreased evodiamine-induced cell death from 57.7 to 47.5% at 24 h. TUNEL assay was carried out to determine the effect of IL-1Ra on evodiamine-induced apoptosis. In the control group, the TUNEL-positive apoptotic cell ratio was about 4.7Ϯ0.6%, IL-1Ra alone did not affect cell viability. In the presence of 15 mM evodiamine at 24 h, 5 mM IL-1Ra reduced the numbers of apoptotic cells from 38.7Ϯ2.8% to 30.6Ϯ2.6% (Fig. 2) . These results demonstrated that IL-1Ra partially blocked A375-S2 cell apoptosis induced by evodiamine.
As an inhibitor of endotoxin, polymyxin B was used to detect whether endotoxin participated in this process. Neither effect of evodiamine nor that of IL-1b, IL-1Ra were influenced by 10 mg/ml polymyxin B ( Table 1 ), indicating that cytokines were free of endotoxin, and contaminated endotoxin did not participate in evodiamine-induced A375-S2 cell death.
Actions of Evodiamine on Fas Death-Inducing Signaling Were Inhibited by IL-1Ra Fas ligation leads to caspase activation, which triggers cell death. 21 ) Thus, we investigated whether the known death receptor ligand Fas-L was involoved in evodiamine-induced cell death in A375-S2 cells. After exposure of 15 mM evodiamine for 0, 6, 12, 24 and 48 h, the expression level of Fas-L began to increase from 6 h. When the cells were pretreated with IL-1Ra for 2 h and then cultured with evodiamine for another 24 h, Fas-L expression was reduced (Fig. 3) .
The effects of IL-1Ra on activation of caspase-8 and -3 induced by evodiamine were measured by their conversion from zymogens to active forms. Consistent with our previous results, 8) procaspase-8 was proteolytically activated after administration with evodiamine 15 mM for 12 h (Fig. 4A) , and procaspase-3 was cleaved as well after 24 h incubation with evodiamine (Fig. 4B) . As expected, pretreatment with 5 mM IL-1Ra partially inhibited degradation of procaspase-8 and -3 at 24 h (Fig. 4) . All these results suggest that IL-1Ra blocked the signaling pathway from engagement of Fas by the Fas-L to proteolytic degradation of procaspase-8 and then activation of downstream caspase-3, which occurred in A375-S2 cells after exposure of evodiamine.
Influence of IL-1Ra on the Course of Evodiamine-Induced Cell Death from Damage to DNA and p53 Activation to Upregulated Bax/Bcl-2 Ratio In response to caspase-3 activation, smear-like DNA degradation was observed after incubation with 15 mM evodiamine for 24 h, and this damage to DNA was attenuated by 5 mM IL-1Ra (Fig. 5) . After DNA damage, p53 activation occurred in evodiamineinduced cell death. Expression of total p53 and phosphorylated p53 were both elevated in a time-dependent fashion, while pretreatment with IL-1Ra reduced up-regulation of p53 and its phosphorylation induced by evodiamine (Fig. 6) .
Activation of p53 in response to DNA damage contributes The cells were cultured with 15 mM evodiamine, 1 nM IL-1b or 5 mM IL-1Ra in the presence or absence of 10 mg/ml polymyxin B for 24 h. The percentage of cell death was determined by MTT assay. The results are representative of three independent experiments. All data were presented as meanϮS.D.
to regulate the balance between members of the Bcl-2 family proteins, which determine the fate of cells. 22, 23) Enhanced expression of proapoptotic protein Bax and decreased antiapoptotic Bcl-2 expression were involved in evodiamine-induced cell death. Pretreatment of IL-1Ra reversed altered expression of Bax and Bcl-2 induced by evodiamine (Fig. 7) . All these results indicated that IL-1Ra was capable of inhibiting the process from DNA damage and p53 activation to enhanced Bax/Bcl-2 ratio involved in evodiamine-induced cell death.
Effects of Anti-IL-1a a and b b on Evodiamine-Induced Cell Death To investigate whether evodiamine actions are mediated by production of IL-1, the cells were treated with 15 mM evodiamine for 24 h in the presence of anti-IL-1a and b. As shown in Table 2 , neither anti-IL-1a nor anti-IL-1b antibody did affect evodiamine-induced A375-S2 cell death. It was suggested that the effects of evodiamine was not mediated by IL-1 production.
IL-1Ra Attenuated p38 MAPK Activation But Not Affected ERK Inactivation P38 and ERK MAPK signaling pathways have been thought to be related to cellular death machinery. 28, 29) After A375-S2 cells were exposed to 15 mM evodiamine for 48 h, expression of p38 protein in a whole cell lysate did not change, whereas the expression of phosphorylated p38 MAPK began to increase from 6 h, peaked at 12 h (Fig. 8A) . However, ERK and phosphorylated ERK expression were down-regulated in a time dependent manner (Fig. 8B) . Pretreatment with 5 mM IL-1Ra reversed the increased expression of phosphorylated p38 MAPK which was evident by treatment with evodiamine at 24 h, but decreased ERK and phosphorylated ERK expression did not change in the presence of IL-1Ra (Fig. 8) . These data suggested that IL-1Ra partially inhibited p38 MAPK but not ERK signaling pathway.
DISCUSSION
In the present study, we showed that IL-1Ra partially inhibited evodiamine-induced Fas death-inducing signaling, which involved activation of caspase-8 and then downstream caspase-3 in A375-S2 cells. Moreover, the process from DNA damage and p53 activation to up-regulated Bax/Bcl-2 ratio upon caspase-3 activation was also attenuated by IL1Ra. Interestingly, IL-1Ra inhibited p38 MAPK activation without affecting ERK inactivation induced by evodiamine.
Stimulation of Fas by its ligand Fas-L induces activation of caspase-8 in a FADD-dependent fashion.
30) Caspase-8 is considered to act independently of other caspases in the initiation phase of Fas signaling. The recruitment of this caspase acts directly on downstream caspases such as caspase-3, which is responsible for the cleavage of death substrates and execution of apoptosis. It has been reported that Fas-L protein expression was increased by addition of IL-1b.
31) The results in our current study showed that evodiamine significantly augmented Fas-L protein expression, IL-1Ra partially inhibited this enhanced Fas-L expression and subsequent steps including the cleavage of pro-caspase-8 and -3. It can be speculated that the inhibitory effect of IL-1Ra on evodiamine-induced cell death might be associated with excreted IL-1 production in A375-S2 cell. However, our results showed that anti-IL-1a or anti-IL-1b did not affect evodiamine-induced cell death. Thus, at the present experimental status, it seems more likely that evodiamine exerted its cytotoxic effect partially through IL-1-induced death cascade by affecting IL-1 receptor or its accessory proteins on A375-S2 cell surface. It is suggested that the protective effect of IL1Ra is due to the competition with evodiamine by affecting the signals at downstream of IL-1 receptors. The more detailed mechanism remained to be elucidated.
In response to activation of caspase-3, the cascade proceeds by coupling DNA damage to p53 activation through its phosphorylation. In particular, pro-apoptotic protein Bax is transcriptionally regulated by p53, 25) and Bcl-2 is cleaved by caspase-3 to alleviate its anti-apoptotic effect. 32) Overexpression ratio of Bax/Bcl-2 triggers translocation of Bax to increase mitochondrial permeability causes the release of proapoptotic factors, including cytochrome c. 33) Released cytochrome c binds to Apaf-1, form the apoptosome, which proteolytically activiates procaspase-9, and in turn activates the effector caspase-3. Pretreatment of IL-1Ra attenuated the events that proceeded from DNA damage through p53 activation to Bax/Bcl-2 up-regulation as a result of caspase activation. Therefore, IL-1Ra may exert its inhibitory effect on caspase-3 through the mitochondria-caspase-9 pathway as well as Fas-caspase-8 pathway.
It is clear that the members of MAPK play important roles in cell proliferation and death. 34) Activation of the distinct MAPK subtype cascade is dependent on the types of cells and the stimuli, and the functional role of each MAPK subtype is different according to the cell types. Consistent with our previous study, expression of phosphorylated p38 was el- evated and ERK, phosphorylated ERK expressions were down-regulated by evodiamine in A375-S2 cells. 8) Importantly, IL-1Ra only alleviated evodiamine-induced p38 MAPK activation but not affected ERK signaling, suggesting that ERK was involved in evodiamine-induced cell death but not in IL-1 mediated signaling pathway. It was coincident with the evidence that IL-1 exhibited its antiproliferative effect on melanoma cells by increasing p38 MAPK activity without altering expression level of ERK and phosphorylated ERK. 20) Although IL-1Ra partially attenuated p38 MAPK activation, IL-1Ra showed no protective effect on evodiamineinduced cell death at later stage. Thus, we speculate that there might be other initiatory targets of evodiamine exist at upstream of p38 MAPK, which is not included in IL-1 signaling pathway, and plays its role mainly at later stage.
Taken together, we elucidated that in evodiamine-induced A375-S2 cell death, Fas associated signaling including activation of caspase-8, -3 and consequent events from DNA damage through p53 activation to up-regulation of Bax/Bcl-2 ratio were involved in IL-1 mediated pathway. However, the suppressive effect of IL-1Ra on the anti-proliferative activity of evodiamine seems relatively weak, suggesting that the inhibitory effect of IL-1Ra on cell signaling proteins was not sufficient to rescue evodiamine-induced cell death. In addition, evodiamine-induced activation of p38 MAPK via phosphorylation but not inactivation of ERK signaling also located at crossing point between evodiamine and IL-1 signaling pathway. However, the more detailed signaling pathway and other crossways unknown remain to be confirmed.
